United States · biotech/health
Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.
Public · NASDAQ:KRTXFor profit
Set against 435 biotech/health companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 92% of those with a size listed; older than 40% of those with a founding year; website ranked #948,321 in the world, about 29k visits a month.
BiopharmaHealth CareTherapeutics
What the source datasets report. We have not watched these rounds ourselves.
$1.6B
raised in total, currency not stated across 7 rounds
Last raised Mar 2023, 3 years ago
Who started it and how it trades.
Everything the source datasets list about Karuna Therapeutics, field by field. Contact details are held but never shown.
The company7 fields
Where2 fields
Size and reach3 fields
Funding, as listed8 fields
About this record2 fields
Growth, as the source summarises it
Karuna Therapeutics was acquired by Bristol Myers Squibb, which strengthened its neuroscience portfolio. Following the acquisition announcement, Karuna Therapeutics saw a rise in its stock price.
435 biotech/health companies in United States, filtered by size, age and reach, ready to export with emails on Pro.